drugset / Trial / NCT00002227

A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00002227 ↗

Phase 2 Completed 60 enrolled Dupont Merck
Treatment

Summary

The purpose of this study is to see if it is safe and effective to give efavirenz plus stavudine plus lamivudine to patients who have never taken anti-HIV drugs.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Efavirenz Other / unclassified — —
Subject Lamivudine Other / unclassified — —
Subject Stavudine Other / unclassified — —